Sri Lanka COVID-19 Emergency Response and Health Systems Preparedness Project

Abstract*

Component 1: Emergency COVID-19 Response: This component will focus on limiting local transmission of COVID-19 through containment strategies and strengthening systems to mitigate future risks. It will (a) support establishment of an Emergency Operation Center atthe Disaster Response and Management unit at the National level to improve coordination and timeliness of national level activities in emergencies of pandemic nature; (b) strengthen systems... Show More

Development Objective

To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Sri Lanka

Key Details

Project Details

Project ID
P173867
Status
Closed
Team Leader
Deepika Eranjanie Attygalle , Srinivas Varadan, Di Dong
Borrower 2
Democratic Socialist Republic of Sri Lanka

Country
Sri Lanka
Disclosure Date
March 25, 2020
Approval Date
(as of board presentation)
April 2, 2020
Effective Date
April 3, 2020

Total Project Cost 1
US$ 298.09 million
Implementing Agency
Ministry of Health,Ministry of Finance,State Ministry of Samurdhi, Household Economy, Micro Finance, Self-Employment, Business Development,
Region
South Asia
Fiscal Year 3
2020

Commitment Amount
US$ 298.09 million
Environmental Category
N/A
Last Update Date
December 31, 2023
Closing Date
December 31, 2023

Consultant Services required
No
Last Stage Reached
BANK APPROVED

Associated Projects
P177714
P176422
P174291

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control100%
- FY17 - Pandemic Response100%
FY17 - Gender66%
FY17 - Health Systems and Policies100%
- FY17 - Health Service Delivery31%
- FY17 - Health System Strengthening73%
- FY17 - Private Sector Delivery in Health31%
FY17 - Nutrition and Food Security11%
- FY17 - Food Security11%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
International Bank for Reconstruction and Development	89.00
Pandemic Emergency Financing Facility	1.72
IDA Credit	207.36

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	89.00
IDA Commitment	207.36
IBRD + IDA Commitment	296.36

Lending Instrument
Grant Amount	1.72
Total Project Cost**	298.09

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

No data available.

Detailed Financial Activity as of March 31, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Feb 15, 2024	IBRD-92960	Int Charges	16,675.57
Feb 15, 2024	IBRD-92960	Int Charges	2,839,244.20
Mar 15, 2024	IDA-67280	Int Charges	11,828.42
Mar 15, 2024	IDA-67280	Int Charges	11,828.42
Mar 15, 2024	IDA-67280	Int Charges	153,204.12
Mar 15, 2024	IDA-67280	Int Charges	153,204.12
Mar 15, 2024	IDA-67280	Int Charges	275,054.20
Mar 19, 2024	IBRD-90850	Loan Disb	-79,431.73
Mar 28, 2024	IBRD-92370	Loan Disb	-2,984,615.20
Mar 28, 2024	IBRD-92370	Loan Disb	2,984,615.20
Mar 28, 2024	IBRD-92370	Loan Disb	-2,984,615.20
Mar 13, 2024	IBRD-92960	Loan Disb	-5,462.50
Aug 15, 2024	IBRD-92370	Int Charges	2,893.07
Aug 15, 2024	IBRD-92370	Int Charges	254,845.62
Aug 15, 2024	IBRD-92960	Int Charges	2,847,580.00
Aug 15, 2024	IDA-68750	Int Charges	3,362.55
Aug 15, 2024	IDA-68750	Int Charges	3,362.55
Aug 15, 2024	IDA-68750	Int Charges	90,565.30
Aug 15, 2024	IDA-68750	Int Charges	90,565.30
Aug 15, 2024	IDA-68750	Int Charges	152,626.23
Aug 15, 2024	IBRD-92370	Int Charges	821,441.70
Aug 15, 2024	IBRD-92960	Int Charges	15,944.53
Aug 15, 2024	IBRD-92960	Int Charges	16,466.05
Nov 15, 2023	IDA-65950	Int Charges	1,835,430.60
Nov 15, 2023	IBRD-90850	Int Charges	558,566.40
Nov 15, 2023	IBRD-90850	Int Charges	130,046.10
Nov 15, 2023	IBRD-90850	Int Charges	2,095.30
Nov 15, 2023	IBRD-90850	Int Charges	4,483.93
Nov 15, 2023	IDA-65950	Int Charges	4,535.08
Sep 15, 2023	IDA-67270	Int Charges	758,222.06
Sep 15, 2023	IDA-67270	Int Charges	4,244.76
Aug 15, 2023	IDA-68750	Int Charges	155,819.00
Sep 15, 2023	IDA-67280	Int Charges	272,393.72
Sep 15, 2023	IDA-67280	Int Charges	5,674.58
Sep 15, 2023	IDA-67280	Int Charges	5,674.58
Aug 15, 2023	IDA-68750	Int Charges	93,491.40
Aug 15, 2023	IDA-68750	Int Charges	93,491.40
Aug 15, 2023	IDA-68750	Int Charges	1,224.75
Sep 15, 2023	IDA-67280	Int Charges	157,761.66
Jun 22, 2020	IDA-67280	Loan Commitment	45,344,700.00
Jun 22, 2020	IDA-67270	Loan Commitment	41,900,000.00
Sep 24, 2021	IBRD-92960	Loan Commitment	100,000,000.00
Apr 27, 2021	IDA-68750	Loan Commitment	26,518,946.00
Apr 27, 2021	IBRD-92370	Loan Commitment	54,000,000.00
Sep 28, 2023	IDA-65950	Loan Disb	-2,038,315.60
May 7, 2024	IBRD-90850	Loan Disb	-2,580,868.80
Sep 28, 2023	IDA-65950	Loan Disb	2,038,315.60
Sep 28, 2023	IDA-65950	Loan Disb	-2,038,315.60
May 7, 2024	IBRD-90850	Loan Disb	-452.01
Apr 2, 2020	IDA-65950	Loan Commitment	93,600,000.00
Apr 2, 2020	IBRD-90850	Loan Commitment	35,000,000.00
May 15, 2024	IBRD-90850	Int Charges	799.06
May 15, 2024	IBRD-90850	Int Charges	4,426.21
May 15, 2024	IBRD-90850	Int Charges	133,233.45
May 15, 2024	IBRD-90850	Int Charges	594,035.94
Feb 15, 2024	IDA-68750	Int Charges	92,393.95
Feb 15, 2024	IDA-68750	Int Charges	92,393.95
Feb 15, 2024	IDA-68750	Int Charges	154,704.45
Feb 15, 2024	IDA-68750	Int Charges	428.73
Feb 15, 2024	IDA-68750	Int Charges	428.73
Feb 15, 2024	IBRD-92370	Int Charges	1,111,634.80
Feb 15, 2024	IBRD-92370	Int Charges	39.46
May 15, 2024	IDA-65950	Int Charges	7,682.59
May 15, 2024	IDA-65950	Int Charges	1,896,931.00
Mar 15, 2024	IDA-67270	Int Charges	4,193.96
Mar 15, 2024	IDA-67270	Int Charges	818,160.50
Feb 15, 2024	IBRD-92960	Int Charges	25,228.84
Sep 15, 2023	IDA-67280	Int Charges	157,761.66
Feb 15, 2023	IDA-68750	Int Charges	2,145.91
Feb 15, 2023	IDA-68750	Int Charges	2,145.91
Feb 15, 2023	IDA-68750	Int Charges	91,698.45
Feb 15, 2023	IDA-68750	Int Charges	91,698.45
Feb 15, 2023	IDA-68750	Int Charges	155,177.89
Mar 15, 2023	IDA-67280	Int Charges	160,228.81
Mar 15, 2023	IDA-67280	Int Charges	160,228.81
Mar 15, 2023	IDA-67280	Int Charges	4,759.12
Mar 15, 2023	IDA-67280	Int Charges	4,759.12
Mar 15, 2023	IDA-67280	Int Charges	274,979.84
Mar 15, 2023	IDA-67270	Int Charges	8,562.64
Mar 15, 2023	IDA-67270	Int Charges	4,175.55
Mar 15, 2023	IDA-67270	Int Charges	840,787.30
Aug 15, 2023	IBRD-92370	Int Charges	38.82
Aug 15, 2023	IBRD-92370	Int Charges	998,540.40
Aug 15, 2023	IBRD-92960	Int Charges	90,973.60
Aug 15, 2023	IBRD-92960	Int Charges	13,059.17
Aug 15, 2023	IBRD-92960	Int Charges	2,455,039.00
May 15, 2023	IBRD-90850	Int Charges	6,794.76
May 15, 2023	IBRD-90850	Int Charges	59,033.56
May 15, 2023	IBRD-90850	Int Charges	538,442.56
May 15, 2023	IDA-65950	Int Charges	0.01
May 15, 2023	IDA-65950	Int Charges	4,461.13
May 15, 2023	IDA-65950	Int Charges	1,769,304.50
Feb 15, 2023	IBRD-92370	Int Charges	1,150,252.20
Feb 15, 2023	IBRD-92370	Int Charges	104,700.46
Feb 15, 2023	IBRD-92960	Int Charges	140,102.56
Feb 15, 2023	IBRD-92960	Int Charges	2,000,655.40
Feb 15, 2023	IBRD-92370	Int Charges	170,899.56
Feb 15, 2023	IBRD-92370	Int Charges	23.81
Feb 10, 2023	IBRD-90850	Loan Disb	4,000,000.00
Sep 15, 2022	IDA-67280	Int Charges	9,422.89
Sep 15, 2022	IDA-67280	Int Charges	9,422.89
Sep 15, 2022	IDA-67270	Int Charges	1,170.51
Sep 15, 2022	IDA-67270	Int Charges	4,529.72
Sep 15, 2022	IDA-67270	Int Charges	185,125.73
Nov 16, 2022	IBRD-90850	Loan Disb	52,443.89
Sep 15, 2022	IDA-67270	Int Charges	329,661.75
Sep 15, 2022	IDA-67270	Int Charges	346.31
Sep 15, 2022	IDA-67280	Int Charges	151,062.45
Sep 15, 2022	IDA-67280	Int Charges	151,062.45
Sep 15, 2022	IDA-67280	Int Charges	267,475.56
Nov 15, 2022	IDA-65950	Int Charges	267,192.28
Nov 15, 2022	IDA-65950	Int Charges	4,535.08
Nov 15, 2022	IDA-65950	Int Charges	1,547,025.90
Nov 15, 2022	IBRD-90850	Int Charges	11,673.33
Nov 15, 2022	IBRD-90850	Int Charges	62,257.67
Nov 15, 2022	IBRD-90850	Int Charges	470,797.72
Dec 28, 2021	IBRD-90850	Loan Disb	172,225.48
Aug 15, 2022	IDA-68750	Int Charges	821.20
Aug 15, 2022	IDA-68750	Int Charges	92,652.16
Aug 15, 2022	IDA-68750	Int Charges	92,652.16
Aug 15, 2022	IDA-68750	Int Charges	154,420.27
Dec 28, 2021	IBRD-90850	Loan Disb	315,663.10
Dec 28, 2021	IBRD-90850	Loan Disb	16,766.72
Dec 28, 2021	IBRD-90850	Loan Disb	783,676.25
Aug 15, 2022	IBRD-92370	Int Charges	267,865.70
Aug 15, 2022	IBRD-92960	Int Charges	591,280.50
Feb 2, 2022	IDA-67270	Loan Disb	1,032,526.30
Jun 3, 2022	IBRD-90850	Loan Disb	16,000,000.00
May 15, 2022	IDA-65950	Int Charges	5,349.14
May 15, 2022	IDA-65950	Int Charges	4,461.14
Mar 15, 2022	IDA-67280	Int Charges	450.34
Mar 15, 2022	IDA-67280	Int Charges	170,429.05
Mar 15, 2022	IDA-67280	Int Charges	170,429.05
Mar 15, 2022	IDA-67280	Int Charges	284,048.38
Mar 15, 2022	IDA-67270	Int Charges	1,730.08
Mar 15, 2022	IDA-67270	Int Charges	13,551.82
Mar 15, 2022	IDA-67270	Int Charges	163,521.88
Feb 15, 2022	IDA-68750	Int Charges	8,138.75
Feb 15, 2022	IDA-68750	Int Charges	8,138.75
Feb 15, 2022	IDA-68750	Int Charges	13,564.59
Feb 15, 2022	IDA-68750	Int Charges	98,297.36
Feb 15, 2022	IDA-68750	Int Charges	98,297.36
Feb 15, 2022	IDA-68750	Int Charges	162,957.70
Jun 28, 2022	IBRD-90850	Loan Disb	-27,389,656.00
Nov 15, 2021	IBRD-90850	Int Charges	500.90
Sep 15, 2021	IDA-67270	Int Charges	1,995.70
Sep 15, 2021	IDA-67270	Int Charges	127,543.16
Nov 3, 2021	IDA-65950	Loan Disb	1,931,130.50
Nov 3, 2021	IDA-65950	Loan Disb	1,500,000.00
Aug 12, 2021	IBRD-92370	Loan Disb	15,327,382.00
Aug 11, 2021	IDA-68750	Loan Disb	16,206,579.00
Aug 15, 2021	IBRD-92370	Int Charges	50,309.11
Sep 13, 2021	IDA-65950	Loan Disb	267,024.70
Sep 13, 2021	IDA-65950	Loan Disb	35,878.32
Sep 13, 2021	IDA-65950	Loan Disb	255,173.60
Sep 13, 2021	IDA-65950	Loan Disb	269,483.75
Sep 13, 2021	IDA-65950	Loan Disb	821,221.56
Sep 13, 2021	IDA-65950	Loan Disb	147,204.56
May 13, 2021	IDA-65950	Loan Disb	6,406,485.00
Jul 13, 2021	IDA-68750	Loan Disb	10,382,580.00
May 17, 2021	IBRD-92370	Loan Disb	135,000.00
Apr 29, 2021	IDA-65950	Loan Disb	6,000,000.00
Jun 1, 2021	IDA-65950	Loan Disb	15,000,000.00
May 17, 2021	IBRD-92370	Fee Charges	135,000.00
Aug 19, 2021	IDA-67270	Loan Disb	2,078,163.60
Sep 21, 2021	IDA-65950	Loan Disb	1,031,217.50
Mar 15, 2021	IDA-67280	Int Charges	57,527.53
Mar 15, 2021	IDA-67280	Int Charges	57,527.53
Mar 15, 2021	IDA-67280	Int Charges	95,879.25
Nov 15, 2020	IBRD-90850	Int Charges	202.13
Nov 15, 2020	IBRD-90850	Int Charges	702.15
Mar 22, 2021	IDA-67280	Loan Disb	2,337,287.80
Nov 15, 2020	IDA-65950	Int Charges	25,950.55
May 15, 2021	IDA-65950	Int Charges	310,327.30
Jun 11, 2021	IBRD-92370	Loan Disb	29,455,102.00
May 15, 2021	IDA-65950	Int Charges	1,331.97
May 15, 2021	IBRD-90850	Int Charges	505.91
Nov 15, 2020	IDA-65950	Int Charges	386,021.62
Oct 14, 2020	IDA-65950	Loan Disb	954,435.00
Oct 26, 2020	IDA-67270	Loan Disb	10,199,233.00
Oct 26, 2020	IDA-67280	Loan Disb	135.61
Mar 8, 2021	IDA-67280	Loan Disb	1,418,452.10
Mar 10, 2021	IDA-67270	Loan Disb	12,177,187.00
Mar 15, 2021	IDA-67280	Loan Disb	24,324,116.00
Mar 15, 2021	IDA-67270	Int Charges	191.22
Mar 15, 2021	IDA-67270	Int Charges	47,424.61
Apr 3, 2020	IDA-65950	Loan Disb	234,000.00
Apr 3, 2020	IDA-65950	Fee Charges	234,000.00
Apr 3, 2020	IBRD-90850	Loan Disb	87,500.00
Apr 3, 2020	IBRD-90850	Fee Charges	87,500.00
Jun 12, 2020	IDA-65950	Loan Disb	21,774,926.00
Jun 9, 2020	IDA-65950	Loan Disb	7,469,279.50
May 21, 2020	IDA-65950	Loan Disb	506,741.94
Apr 24, 2020	IDA-65950	Loan Disb	22,000,000.00
Oct 19, 2020	IDA-67280	Loan Disb	18,662,304.00
Jul 24, 2020	IDA-67270	Loan Disb	104,750.00
Jul 24, 2020	IDA-67270	Fee Charges	104,750.00
Jul 21, 2020	IDA-65950	Loan Disb	732,403.90
Jun 28, 2022	IBRD-90850	Loan Disb	27,389,656.00
Jun 28, 2022	IBRD-92370	Loan Disb	53,968,672.00
Jun 28, 2022	IBRD-92370	Loan Disb	-53,968,672.00
Feb 15, 2022	IBRD-92960	Int Charges	274,376.66
May 15, 2022	IDA-65950	Int Charges	524,908.75
May 15, 2022	IDA-65950	Int Charges	1,510.10
Feb 15, 2022	IBRD-92370	Int Charges	1,200.65
Feb 15, 2022	IBRD-92370	Int Charges	241,469.70
May 15, 2022	IBRD-90850	Int Charges	2,812.10
May 15, 2022	IBRD-90850	Int Charges	9,961.09
May 15, 2022	IBRD-90850	Int Charges	29,649.81
May 15, 2022	IBRD-90850	Int Charges	64,641.94
Apr 22, 2022	IDA-67270	Loan Disb	670,112.90
Apr 6, 2022	IBRD-92960	Loan Disb	4,621,528.00
Mar 22, 2022	IBRD-92960	Loan Disb	1,387,918.80
Dec 16, 2021	IDA-67280	Loan Disb	277,395.88
Jun 28, 2022	IDA-67270	Loan Disb	-38,531,892.00
Jun 28, 2022	IDA-67270	Loan Disb	38,531,892.00
Jun 28, 2022	IDA-65950	Loan Disb	90,001,504.00
Jun 28, 2022	IDA-65950	Loan Disb	-90,001,504.00
Mar 7, 2022	IDA-67270	Loan Disb	1,028,391.06
Dec 14, 2021	IDA-67270	Loan Disb	11,049,342.00
Jun 7, 2022	IDA-67270	Loan Disb	192,187.06
Nov 15, 2021	IDA-65950	Int Charges	459,714.84
Sep 30, 2021	IDA-65950	Loan Disb	2,664,896.80
Sep 15, 2021	IDA-67280	Int Charges	722.67
Sep 15, 2021	IDA-67280	Int Charges	722.67
Sep 15, 2021	IDA-67280	Int Charges	174,608.05
Sep 15, 2021	IDA-67280	Int Charges	174,608.05
Sep 15, 2021	IDA-67280	Int Charges	291,752.25
Sep 28, 2021	IBRD-92960	Loan Disb	250,000.00
Sep 28, 2021	IBRD-92960	Fee Charges	250,000.00
Sep 29, 2021	IBRD-92960	Loan Disb	80,500,000.00
Oct 5, 2021	IBRD-90850	Loan Disb	10,013,824.00
Nov 15, 2021	IDA-65950	Int Charges	3,475.96
Nov 15, 2021	IDA-65950	Int Charges	11,951.94
Sep 2, 2021	IBRD-92370	Loan Disb	9,051,186.00
Nov 15, 2021	IBRD-90850	Int Charges	36,882.93

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Progress towards achievement of PDO	Satisfactory	2024-04-17
Financial Management	Satisfactory	2024-04-17
Monitoring and Evaluation	Satisfactory	2024-04-17
Procurement	Satisfactory	2024-04-17
Project Management	Satisfactory	2024-04-17
Overall Implementation Progress (IP)	Satisfactory	2024-04-17

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Emergency Operations Centre for COVID-19 and pandemic responses established Value No Yes Yes
Date April 1, 2020 December 31, 2023 December 31, 2023
Comment
Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents Value 5.00 17.00 17.00
Date April 1, 2020 December 31, 2023 December 31, 2020
Comment
Percentage of health districts with a tertiary or secondary care hospital with isolation capacity Value 8.00 100.00 100.00
Date April 1, 2020 December 31, 2023 December 31, 2023
Comment

Percentage of population vaccinated, which is included in the priority population targets defined in the NDVP, disaggregated by gender	Value	0.01	98.00	56.80
	Date	February 18, 2021	December 31, 2023	December 31, 2023
	Comment

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Number of ICU beds in tertiary and secondary hospitals against planned Value 560.00 750.00 750.00
Date April 1, 2020 December 31, 2023 December 31, 2023
Comment
Number of individual isolation rooms established within the National Institute of Infectious Diseases established Value 0.00 48.00 24.00
Date April 1, 2020 December 31, 2023 December 31, 2023
Comment

Number of peer-reviewed publications from Research Institutions supported to undertake research and monitor progress and capacity of the health system for pandemic preparedness	Value	0.00	5.00	5.00
	Date	April 1, 2020	December 31, 2023	December 31, 2023
	Comment

National protocols for detection, surveillance, and response systems for animal and human health infections Value No Yes Yes
Date April 1, 2020 December 31, 2023 December 31, 2023
Comment
Number of health staff trained in infection prevention and control per MoH approved protocols Value 100.00 30000.00 1000.00
Date April 1, 2020 December 31, 2023 December 31, 2023
Comment
Percentage of received grievances that are addressed within 30 days Value 0.00 100.00 80.00
Date November 28, 2021 December 31, 2023 December 31, 2023
Comment

Number of secondary and tertiary care hospitals with environmental protection license (EPL) and Scheduled waste license (SWL)	Value	20.00	335.00	81.00
	Date	April 1, 2020	December 31, 2023	December 31, 2023
	Comment

Number of secondary and tertiary care hospitals with networked laboratory information system in place Value 0.00 0.00 50.00
Date April 1, 2020 December 31, 2023 December 31, 2021
Comment
Guidelines to engage private health facilities in supporting pandemic response Value No Yes Yes
Date April 1, 2020 December 31, 2023 December 31, 2023
Comment
Number of sub-national emergency operational centers with an established quarantine mechanism Value 8.00 28.00 26.00
Date April 1, 2020 December 31, 2023 December 31, 2023
Comment
Number of secondary and tertiary hospitals with solar energy backup to overcome electricity outages Value 0.00 0.00 1.00
Date April 1, 2020 December 31, 2023 December 31, 2020
Comment
Number of secondary and tertiary care hospitals with classified accredited labs Value 0.00 50.00 50.00
Date April 1, 2020 December 31, 2023 December 31, 2023
Comment

Number of field staff engaged in elder care, homes for the people with special needs and orphanages trained and equipped for prevention and care measures	Value	100.00	1000.00	1000.00
	Date	April 1, 2020	December 31, 2023	December 31, 2023
	Comment

Number of beneficiaries provided with cash transfers in response to COVID-19 Value 0.00 3150429.00 600000.00
Date April 1, 2020 December 31, 2023 August 31, 2020
Comment
Risk communication plan implemented Value No Yes Yes
Date April 1, 2020 December 31, 2023 March 31, 2021
Comment
Number of individuals utilizing GBV services through the Mithuru Piyasas Value 9000.00 16350.00 12000.00
Date April 1, 2020 December 31, 2023 December 31, 2023
Comment
Number of women utilizing gender-based violence services through the Mithuru Piyasas Value 8500.00 15510.00 11000.00
Date April 1, 2020 December 31, 2023 December 31, 2023
Comment
Number of children and men utilizing gender-based violence services through the Mithuru Piyasas Value 500.00 841.00 1000.00
Date April 1, 2020 December 31, 2023 December 31, 2023
Comment

National Deployment and Vaccination Plan for COVID-19 vaccines with input from relevant bodies is updated by the government, as needed	Value	No	Yes	Yes
	Date	February 18, 2021	December 31, 2023	December 31, 2023
	Comment

Number of districts with functional vaccination tracking system/HMIS collecting sex and age disaggregated data on COVID-19 vaccinesat district level	Value	3.00	25.00	25.00
	Date	February 18, 2021	December 31, 2023	December 31, 2023
	Comment

Percentage of health districts with a tertiary or secondary care hospital with isolation capacity	Value	8.00	100.00	100.00
	Date	April 1, 2020	December 31, 2023	December 31, 2023
	Comment

Number of ICU beds in tertiary and secondary hospitals against planned	Value	560.00	750.00	750.00
	Date	April 1, 2020	December 31, 2023	December 31, 2023
	Comment

Risk communication plan implemented	Value	No	Yes	Yes
	Date	April 1, 2020	December 31, 2023	March 31, 2021
	Comment

Number of individuals utilizing GBV services through the Mithuru Piyasas	Value	9000.00	16350.00	12000.00
	Date	April 1, 2020	December 31, 2023	December 31, 2023
	Comment

Number of women utilizing gender-based violence services through the Mithuru Piyasas	Value	8500.00	15510.00	11000.00
	Date	April 1, 2020	December 31, 2023	December 31, 2023
	Comment

Number of children and men utilizing gender-based violence services through the Mithuru Piyasas	Value	500.00	841.00	1000.00
	Date	April 1, 2020	December 31, 2023	December 31, 2023
	Comment

Sri Lanka COVID-19 Emergency Response and Health Systems Preparedness Project

Abstract*

Development Objective

Key Details

Project Details

Sectors

Themes

Stay Connected, sign up for our:

Project Map

Finances

Financing Plan (US$ Millions)

Total Project Financing (US$ Millions)

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Detailed Financial Activity as of March 31, 2025

Ratings

IMPLEMENTATION RATINGS

COMPLETION RATINGS

INDEPENDENT EVALUATION RATINGS

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INTERMEDIATE RESULTS INDICATORS